Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis

Cystatin SN, a specific cysteine protease inhibitor, is thought to be involved in various malignant tumors. Therefore, we evaluated the role of cystatin SN in hepatocellular carcinoma (HCC). Notably, cystatin SN was elevated in tumorous samples and cells. Moreover, overexpression of cystatin SN was...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Cell Physiol
Главные авторы: Cui, Yifeng, Sun, Dan, Song, Ruipeng, Zhang, Shugeng, Liu, Xirui, Wang, Yan, Meng, Fanzheng, Lan, Yaliang, Han, Jihua, Pan, Shangha, Liang, Shuhang, Zhang, Bo, Guo, Hongrui, Liu, Yufeng, Lu, Zhaoyang, Liu, Lianxin
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2019
Предметы:
Original Research Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6767558/
https://ncbi.nlm.nih.gov/pubmed/31106426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.28828
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы